Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma

Table 5

2×2 Table of PET/CT with distant metastatic disease.

+ PET/CT with metastatic disease	Confirmed metastatic disease
Frequency percent
	(a) Disease present	(b) No Disease	Total
(a) Positive test	5	3	8
	7.27	5.45	12.73
(b) Negative test	0	48	48
	0.00	87.27	87.27
Total	5	51	56
	7.27	92.73	100.00